Akebia Therapeutics, Inc.
Nasdaq · CIK 0001517022 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Akebia Therapeutics, Inc. | 2026-07-01 | 0001762507-26-000004 |
| 4 | Akebia Therapeutics, Inc. | 2026-06-22 | 0001808317-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-06-22 | 0001609480-26-000003 |
| 4 | Akebia Therapeutics, Inc. | 2026-06-22 | 0001244159-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-06-22 | 0001890219-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-06-22 | 0001204946-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-06-22 | 0001248144-26-000001 |
| 10-Q | Akebia Therapeutics, Inc. | 2026-05-07 | 0001517022-26-000039 |
| 4 | Akebia Therapeutics, Inc. | 2026-03-05 | 0001591467-26-000003 |
| 10-K | Akebia Therapeutics, Inc. | 2026-02-26 | 0001517022-26-000020 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-04 | 0002007730-26-000002 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-04 | 0001661887-26-000002 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-04 | 0001619834-26-000002 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-04 | 0002107264-26-000006 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-04 | 0001762507-26-000002 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-04 | 0001591467-26-000002 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-03 | 0001619834-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-03 | 0002107264-26-000005 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-03 | 0002007730-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-03 | 0001762507-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-03 | 0001591467-26-000001 |
| 4 | Akebia Therapeutics, Inc. | 2026-02-03 | 0001661887-26-000001 |
| 10-Q | Akebia Therapeutics, Inc. | 2025-11-10 | 0001517022-25-000046 |
| 10-Q | Akebia Therapeutics, Inc. | 2025-08-07 | 0001628280-25-038600 |